Polyvinylpyrrolidone

Théa Introduces iVIZIA™ OTC Eye-Care Products in U.S.

Retrieved on: 
Saturday, April 23, 2022
Science, Other Science, Research, Pharmaceutical, Optical, General Health, Health, Other Health, Water, Hyaluronic acid, Dry, Polyvinylpyrrolidone, Hygiene, Oil, Eye, Trehalose, Duane syndrome, Research, Dry eye syndrome, Sodium hyaluronate, OTC, Patient, OD, Stinger, General manager, No, Eyelid, Amazon, Quality of life, Partnership, Viscosity, Ear, CVS, Cosmetics, Hospital

Tha Pharma Inc. (Tha), the U.S. subsidiary of Europes leading independent pharmaceutical company specializing in the research, development and commercialization of eye-care products, today announced the availability of the iVIZIA line of over-the-counter (OTC) eye-care products in the United States.

Key Points: 
  • Tha Pharma Inc. (Tha), the U.S. subsidiary of Europes leading independent pharmaceutical company specializing in the research, development and commercialization of eye-care products, today announced the availability of the iVIZIA line of over-the-counter (OTC) eye-care products in the United States.
  • The iVIZIA OTC product line includes lubricating eye drops, lubricating eye gel, and three options for daily hygiene of sensitive eyelids.
  • They gently remove oils and makeup from dry, irritated, sensitive eyelids: iVIZIA Eyelid Cleansing Wipes, iVIZIA Micellar Eyelid Cleanser, and iVIZIA Eyelid Cleansing Gel.
  • The iVIZIA brand is being distributed by Colorado-based Similasan Corporation , known for its natural, homeopathic products for eye, ear, sinus and cold relief.

Rising Demand for High Performance Water-soluble Polymers Boosts Growth of Polyvinylpyrrolidone Market

Retrieved on: 
Tuesday, February 9, 2021
Excipients, Food additives, Bazaars, Marketplace, Polyvinylpyrrolidone, Chemical substances, Chemistry

According to analysts at Transparency Market Research (TMR), the global polyvinylpyrrolidone market will expand at a promising CAGR of over 13% throughout the forecast period 20192027.

Key Points: 
  • According to analysts at Transparency Market Research (TMR), the global polyvinylpyrrolidone market will expand at a promising CAGR of over 13% throughout the forecast period 20192027.
  • Thus, the market for polyvinylpyrrolidone is likely to account for around US$ 7.5 Bn by the end of 2027.
  • In recent few years, there is extensive growth in demand for high performance water-soluble polymers.
  • Owing to this scenario, vendors in the global polyvinylpyrrolidone market are foreseen to gain promising demand opportunities throughout the forecast period 20192027.

Purdue Pharma’s Avrio Health Launches Betadine® Antiseptic Oral Rinse for Professional Use

Retrieved on: 
Monday, February 8, 2021
Medical Supplies, Health, Surgery, Other Health, Dental, Pharmaceutical, Health, Chemistry, Physical sciences, RTT, Dosage forms, Antiseptics, Disinfectants, Polyvinylpyrrolidone, Mouthwash, Topical medication, Povidone-iodine, Iodine, Betadine, Avrio Health L.P., Purdue Pharma L.P.

Avrio Health L.P. (Avrio), a subsidiary of Purdue Pharma L.P. (Purdue), today announced the launch of new Betadine Antiseptic Oral Rinse (active ingredient 0.5% povidone-iodine, or PVP-I), an oral antiseptic pre-procedural rinse.

Key Points: 
  • Avrio Health L.P. (Avrio), a subsidiary of Purdue Pharma L.P. (Purdue), today announced the launch of new Betadine Antiseptic Oral Rinse (active ingredient 0.5% povidone-iodine, or PVP-I), an oral antiseptic pre-procedural rinse.
  • Betadine antiseptic products have been used in the hospital and outpatient settings for their antiseptic (antimicrobial) properties for more than 50 years.
  • Betadine Antiseptic Oral Rinse should be administered by professionals and used orally (do not swallow) in preparation of the oral mucosa prior to injection, dental surgery, or tooth extraction.
  • Betadine Topical Antiseptic products currently available in the U.S. are for external use only and should not be gargled or swallowed.

Purdue’s Avrio Health L.P. Reports Preliminary In Vitro Test Results on Study Assessing Betadine Gargle Against COVID-19

Retrieved on: 
Thursday, August 13, 2020
Health, Infectious diseases, General Health, Clinical trials, Research, Science, Pharmaceutical, Sarbecovirus, Health, Microbiology, Animal diseases, Antiseptics, Disinfectants, Iodine, Povidone-iodine, RTT, Polyvinylpyrrolidone, Severe acute respiratory syndrome, Coronavirus

Avrio Health L.P., a subsidiary of Purdue Pharma L.P. (Purdue), is reporting encouraging preliminary results of an in vitro (laboratory) study assessing Betadine Antiseptic Sore Throat Gargle (active ingredient, povidone-iodine or PVP-I) against the virus causing COVID-19.

Key Points: 
  • Avrio Health L.P., a subsidiary of Purdue Pharma L.P. (Purdue), is reporting encouraging preliminary results of an in vitro (laboratory) study assessing Betadine Antiseptic Sore Throat Gargle (active ingredient, povidone-iodine or PVP-I) against the virus causing COVID-19.
  • Preliminary results show Betadine Gargle killed 99.9 percent of the virus within 15 seconds.
  • Betadine Gargle containing 0.5% PVP-I demonstrated virucidal activity against SARS-CoV-2 and four surrogate coronaviruses in three separate in vitro studies.
  • An in vitro study conducted by Utah State University, Institute for Antiviral Research, assessed virucidal activity of Betadine Gargle against SARS-CoV-2.

Purdue Pharma’s Avrio Health Expands Betadine® Portfolio With New Over-The-Counter Antiseptic Sore Throat Gargle

Retrieved on: 
Tuesday, August 11, 2020
General Health, Pharmaceutical, Health, Chemistry, Physical sciences, Chemical substances, RTT, Antiseptics, Disinfectants, Povidone-iodine, Polyvinylpyrrolidone, Iodine, PvP

Avrio Health L.P. (Avrio), a subsidiary of Purdue Pharma L.P. (Purdue), today announced the launch of new Betadine Antiseptic Sore Throat Gargle (active ingredient povidone-iodine, or PVP-I), an oral antiseptic with use for the temporary relief of occasional sore throat.

Key Points: 
  • Avrio Health L.P. (Avrio), a subsidiary of Purdue Pharma L.P. (Purdue), today announced the launch of new Betadine Antiseptic Sore Throat Gargle (active ingredient povidone-iodine, or PVP-I), an oral antiseptic with use for the temporary relief of occasional sore throat.
  • Betadine Antiseptic Sore Throat Gargle should be used orally (do not swallow) for the temporary relief of occasional sore throat.
  • Betadine Antiseptic Sore Throat Gargle can be used by adults and children 12 years of age and older.
  • Betadine Sore Throat Gargle (0.5% povidone-iodine antiseptic gargle), which should not be ingested, relieves sore throat.

Purdue Pharma’s Avrio Health Donates Betadine® Antiseptic Products to Direct Relief for Use by Frontline Healthcare Workers

Retrieved on: 
Thursday, July 16, 2020
Medical devices, Medical Supplies, Infectious diseases, Philanthropy, Biotechnology, General Health, Pharmaceutical, Health, Other Philanthropy, Oncology, Chemistry, Physical sciences, Chemical substances, RTT, Antiseptics, Disinfectants, Sackler family, Polyvinylpyrrolidone, Povidone-iodine, Iodine, PvP, Surgery, Avrio Health L.P., Purdue Pharma L.P., Direct Relief

Avrio Health L.P. (Avrio), a subsidiary of Purdue Pharma L.P. (Purdue), has donated shipments of Betadine Solution and Surgical Scrub to Direct Relief , advancing the companys previous commitment to donate $1.6 million worth of Betadine antiseptic products (active ingredient, povidone-iodine or PVP-I) for use by frontline healthcare workers.

Key Points: 
  • Avrio Health L.P. (Avrio), a subsidiary of Purdue Pharma L.P. (Purdue), has donated shipments of Betadine Solution and Surgical Scrub to Direct Relief , advancing the companys previous commitment to donate $1.6 million worth of Betadine antiseptic products (active ingredient, povidone-iodine or PVP-I) for use by frontline healthcare workers.
  • Betadine Solution and Betadine Surgical Scrub are antiseptic products for healthcare professionals to use to reduce the number of microorganisms on the skin that can potentially cause infection.
  • Betadine antiseptic products have been used by healthcare professionals for more than 50 years.
  • We have supported Direct Relief both recently and historically with a COVID-19 special donation grant and product donations tied to hurricane relief efforts.

Laboratory Studies Confirm BETADINE® Antiseptic Products’ Effectiveness Against COVID-19 Virus

Retrieved on: 
Thursday, July 9, 2020
Medical Supplies, Retail, Health, Infectious diseases, Home Goods, Clinical trials, Health, Chemistry, Physical sciences, RTT, Zoonoses, Antiseptics, Disinfectants, Iodine, Povidone-iodine, Polyvinylpyrrolidone, PvP, Mouthwash, Mundipharma, BETADINE®

Mundipharma today announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE antiseptic products against the novel coronavirus (SARS-CoV-2) which causes COVID-19 disease.

Key Points: 
  • Mundipharma today announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE antiseptic products against the novel coronavirus (SARS-CoV-2) which causes COVID-19 disease.
  • The products subjected to testing were: BETADINE antiseptic products, namely Solution (10% PVP-I), Skin Cleanser (7.5% PVP-I), Gargle and Mouthwash (1.0% PVP-I) and Throat Spray (0.45% PVP-I).
  • These results confirm our view that BETADINE antiseptic products, used appropriately and in conjunction with other preventative treatment options including PPE, can play a role in limiting the spread of infections, including COVID-19, said Raman Singh, CEO Mundipharma.
  • In-vitro and clinical studies have demonstrated that BETADINE povidone iodine kills a broad range of bacteria, viruses and fungi including antibiotic-resistant strains.

BD Launches First and Only Fully Sterile Povidone-Iodine and Isopropyl Alcohol Skin Preparation

Retrieved on: 
Tuesday, July 7, 2020
Chemistry, Antiseptics, Chemical substances, Physical sciences, Disinfectants, RTT, Povidone-iodine, Chlorhexidine, Asepsis, Isopropyl alcohol, Polyvinylpyrrolidone, Iodine

FRANKLIN LAKES, N.J., July 7, 2020 /PRNewswire/ --BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the availability of BD PurPrep patient preoperative skin preparation with sterile solution, the first and only fully sterile povidone-iodine plus isopropyl alcohol single-use antiseptic skin preparation (PVP-I; 0.83% available iodine and 72.5% isopropyl alcohol) commercially available in the United States.

Key Points: 
  • FRANKLIN LAKES, N.J., July 7, 2020 /PRNewswire/ --BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the availability of BD PurPrep patient preoperative skin preparation with sterile solution, the first and only fully sterile povidone-iodine plus isopropyl alcohol single-use antiseptic skin preparation (PVP-I; 0.83% available iodine and 72.5% isopropyl alcohol) commercially available in the United States.
  • BD PurPrep joins BD ChloraPreppatient preoperative skin preparation as the only fully sterile skin preparations available on the market that use a single-use applicator specifically designed to prevent cross-contamination and promote aseptic non-touch technique.
  • "Sterile single-use products have been shown to reduce the risk of outbreaks linked to microbial contamination of antiseptic products.
  • Like BD ChloraPrep, the new BD PurPrep sterile solution will include a mark to indicate that the solution is sterile.

Laboratory Studies Confirm the Effectiveness of BETADINE® Gargle and Mouthwash Against COVID-19 Virus

Retrieved on: 
Tuesday, June 30, 2020
Infectious diseases, Health, Science, Research, Dental, Chemistry, Physical sciences, Chemical substances, Disinfectants, Antiseptics, Iodine, Povidone-iodine, RTT, Dosage forms, Polyvinylpyrrolidone, PvP, Mouthwash, TIDREC, Mundipharma, BETADINE®

BETADINE Gargle and Mouthwash was tested for virucidal activity in two concentrations, undiluted (PVP-I 1% w/v) and at a 1:2 dilution (PVP-I 0.5% w/v) under established European (EN14476) methodology and standards.

Key Points: 
  • BETADINE Gargle and Mouthwash was tested for virucidal activity in two concentrations, undiluted (PVP-I 1% w/v) and at a 1:2 dilution (PVP-I 0.5% w/v) under established European (EN14476) methodology and standards.
  • The testing demonstrated strong in-vitro virucidal activity, with the tested products killing 99.99% of the SARS-CoV-2 virus in just 15 seconds.
  • The TIDREC research has been accepted by the British Dental Journal (BDJ) and was published as a Letter on 26 June 2020.
  • In-vitro and clinical studies have demonstrated that BETADINE Povidone-iodine kills a broad range of bacteria, viruses and fungi including antibiotic-resistant strains.

The Global Poly Vinyl Pyrrolidone Market is expected to grow from USD 2,663.04 Million in 2018 to USD 4,184.23 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.66%

Retrieved on: 
Thursday, May 28, 2020
Organizations, International organizations, World, Adhesive, Polyvinylpyrrolidone, Pyrrolidone, European Union

On the basis of Application, the Global Poly Vinyl Pyrrolidone Market is studied across Adhesives, Cosmetics, Food & Beverages, Pharmaceutical, and Solvents.

Key Points: 
  • On the basis of Application, the Global Poly Vinyl Pyrrolidone Market is studied across Adhesives, Cosmetics, Food & Beverages, Pharmaceutical, and Solvents.
  • What are the factors that affect the growth in the Global Poly Vinyl Pyrrolidone Market over the forecast period?
  • Which are the best product areas to be invested in over the forecast period in the Global Poly Vinyl Pyrrolidone Market?
  • What are the modes of entering the Global Poly Vinyl Pyrrolidone Market?